Cargando…

Combination therapy of Juzentaihoto and mesenchymal stem cells attenuates liver damage and regresses fibrosis in mice

BACKGROUND: Liver cirrhosis is an end-stage multiple liver disease. Mesenchymal stem cells (MSCs) are an attractive cell source for reducing liver damage and regressing fibrosis; additional therapies accompanying MSCs can potentially enhance their therapeutic effects. Kampo medicines exhibit anti-in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iwasawa, Takahiro, Nojiri, Shunsuke, Tsuchiya, Atsunori, Takeuchi, Suguru, Watanabe, Takayuki, Ogawa, Masahiro, Motegi, Satoko, Sato, Takeki, Kumagai, Masaru, Nakaya, Taiki, Ohbuchi, Katsuya, Nahata, Miwa, Fujitsuka, Naoki, Takamura, Masaaki, Terai, Shuji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japanese Society for Regenerative Medicine 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340055/ https://www.ncbi.nlm.nih.gov/pubmed/34409135 http://dx.doi.org/10.1016/j.reth.2021.07.002

Ejemplares similares

A novel prostaglandin I(2) agonist, ONO-1301, attenuates liver inflammation and suppresses fibrosis in non-alcoholic steatohepatitis model mice
por: Motegi, Satoko, et al.
Publicado: (2022)

Synthesized HMGB1 peptide attenuates liver inflammation and suppresses fibrosis in mice
por: Nojiri, Shunsuke, et al.
Publicado: (2021)

Therapeutic potential of mesenchymal stem cells and their exosomes in severe novel coronavirus disease 2019 (COVID-19) cases
por: Tsuchiya, Atsunori, et al.
Publicado: (2020)

Development of a non-alcoholic steatohepatitis model with rapid accumulation of fibrosis, and its treatment using mesenchymal stem cells and their small extracellular vesicles
por: Watanabe, Takayuki, et al.
Publicado: (2020)

Mesenchymal stem cells cultured under hypoxic conditions had a greater therapeutic effect on mice with liver cirrhosis compared to those cultured under normal oxygen conditions
por: Kojima, Yuichi, et al.
Publicado: (2019)

Daisaikoto improves fatty liver and obesity in melanocortin-4 receptor gene-deficient mice via the activation of brown adipose tissue
por: Morita, Shinichi, et al.
Publicado: (2022)

Mesenchymal stem cell therapies for liver cirrhosis: MSCs as “conducting cells” for improvement of liver fibrosis and regeneration
por: Tsuchiya, Atsunori, et al.
Publicado: (2019)

Decline in Liver Mitochondria Metabolic Function Is Restored by Hochuekkito Through Sirtuin 1 in Aged Mice With Malnutrition
por: Nahata, Miwa, et al.
Publicado: (2022)

Small extracellular vesicles derived from interferon-γ pre-conditioned mesenchymal stromal cells effectively treat liver fibrosis
por: Takeuchi, Suguru, et al.
Publicado: (2021)

Benign Duodenal Stenosis Caused by Huge Mesenteric Hematoma Conservatively Improved with Long-term Use of Double Elementary Diet Tube
por: Setsu, Toru, et al.
Publicado: (2021)

Transition of clinical and basic studies on liver cirrhosis treatment using cells to seek the best treatment
por: Terai, Shuji, et al.
Publicado: (2021)

Novel Strategy for Diagnosis of Focal Nodular Hyperplasia Using Gadolinium Ethoxybenzyl Diethylenetriaminepentaacetic Acid: Enhanced Magnetic Resonance Imaging and Magnetic Resonance Elastography
por: Takeda, Nobutaka, et al.
Publicado: (2021)

Effects of Human Adipose Tissue-Derived and Umbilical Cord Tissue-Derived Mesenchymal Stem Cells in a Dextran Sulfate Sodium-Induced Mouse Model
por: Ikarashi, Shunzo, et al.
Publicado: (2019)

Molecular Mechanisms and Treatment of Sarcopenia in Liver Disease: A Review of Current Knowledge
por: Kamimura, Hiroteru, et al.
Publicado: (2021)

Spontaneous regression of hepatocellular carcinoma: A mini-review
por: Sakamaki, Akira, et al.
Publicado: (2017)

Listeria Meningitis during Infliximab-based Treatment for Ulcerative Colitis
por: Tsuchiya, Atsunori, et al.
Publicado: (2018)

Lusutrombopag increases hematocytes in a compensated liver cirrhosis patient
por: Sakamaki, Akira, et al.
Publicado: (2017)

Increase of Soluble Programmed Cell Death Ligand 1 in Patients with Chronic Hepatitis C
por: Yamagiwa, Satoshi, et al.
Publicado: (2017)

Efficacy of Juzentaihoto for Tumor Immunotherapy in B16 Melanoma Metastasis Model
por: Ishikawa, Shintaro, et al.
Publicado: (2017)

Rikkunshito Ameliorates Cancer Cachexia Partly through Elevation of Glucarate in Plasma
por: Ohbuchi, Katsuya, et al.
Publicado: (2015)

Bleeding from a Small-Intestinal Ulcer Associated with Chronic Hepatitis C
por: Kamimura, Hiroteru, et al.
Publicado: (2018)

Renal Impairment in Chronic Hepatitis B: A Review
por: Kamimura, Hiroteru, et al.
Publicado: (2018)

Long-term efficacy and safety of nalfurafine hydrochloride on pruritus in chronic liver disease patients: Patient-reported outcome based analyses
por: Kamimura, Kenya, et al.
Publicado: (2017)

EpCAM- and/or NCAM-Expressing Hepatocellular Carcinoma in Which Behavior of Hepatic Progenitor Cell Marker-Positive Cells Are Followed
por: Tsuchiya, Atsunori, et al.
Publicado: (2019)

Refractory hemorrhagic esophageal ulcers by Candida esophagitis with advanced systemic sclerosis
por: Natsui, Kazuki, et al.
Publicado: (2020)

Changes in Magnetic Resonance Imaging Findings in a Malignant Melanoma Patient
por: Setsu, Toru, et al.
Publicado: (2020)

The development of mesenchymal stem cell therapy in the present, and the perspective of cell-free therapy in the future
por: Watanabe, Yusuke, et al.
Publicado: (2021)

Diverse perspectives to address for the future treatment of heterogeneous hepatocellular carcinoma
por: Tsuchiya, Atsunori, et al.
Publicado: (2019)

Suppressive Effect of Juzentaihoto on Vascularization Induced by B16 Melanoma Cells In Vitro and In Vivo
por: Ishikawa, Shintaro, et al.
Publicado: (2012)

Japanese Kampo Medicine Juzentaihoto Improves Antiviral Cellular Immunity in Tumour-Bearing Hosts
por: Takaku, Shun, et al.
Publicado: (2022)

Juzentaihoto Failed to Augment Antigen-Specific Immunity but Prevented Deterioration of Patients' Conditions in Advanced Pancreatic Cancer under Personalized Peptide Vaccine
por: Yutani, Shigeru, et al.
Publicado: (2013)

Protective effect of the Japanese traditional medicine juzentaihoto on myelosuppression induced by the anticancer drug TS-1 and identification of a potential biomarker of this effect
por: Ogawa, Kazuo, et al.
Publicado: (2012)

Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies
por: Kobayashi, Takamasa, et al.
Publicado: (2018)

Prognostic value of subcutaneous adipose tissue volume in hepatocellular carcinoma treated with transcatheter intra-arterial therapy
por: Kobayashi, Takamasa, et al.
Publicado: (2018)

Transhepatic arterial infusion chemotherapy using a combination of miriplatin and CDDP powder versus miriplatin alone in the treatment of hepatocellular carcinoma: a randomized controlled trial
por: Kamimura, Kenya, et al.
Publicado: (2017)

Usefulness of a Kampo Medicine on Stress-Induced Delayed Gastric Emptying in Mice
por: Mogami, Sachiko, et al.
Publicado: (2020)

Data of RNA-seq transcriptomes of liver, bone, heart, kidney and blood in klotho mice at a pre-symptomatic state and the effect of a traditional Japanese multi-herbal medicine, juzentaihoto
por: Okada, Norihiro, et al.
Publicado: (2022)

Stomach Dysfunction Is a Potential Risk Factor for Wernicke's Encephalopathy
por: Nakano, Oki, et al.
Publicado: (2016)

Invasive Liver Abscess Syndrome Caused by Klebsiella pneumoniae
por: Setsu, Toru, et al.
Publicado: (2017)

Disappearance of multiple pancreatic cysts after prednisolone treatment in a patient with autoimmune pancreatitis
por: Kohisa, Junji, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hk5idn26682d17hvlqkef45q0j